NEW YORK — When Dr. Alois Alzheimer first identified the disease that would bear his name in 1906, he could only confirm his diagnosis by examining brain tissue after a patient’s death. More than a ...

If further studies confirm their latest findings, Nasca says the team's research could be used to develop a blood test for dementia and for tracking the progression of Alzheimer's disease in an ...

If further studies confirm their latest findings, Nasca says the team's research could be used to develop a blood test for dementia and for tracking the progression of Alzheimer's disease in an ...

The Montreal Cognitive Assessment (MoCA) is a test used to detect mild cognitive decline and early signs of dementia. It can help identify people at risk of Alzheimer's disease and screen for ...

The Know Your Hearing Campaign aims to boost public awareness of the importance of knowing your Hearing Number, which ...

The team’s goal is to define other biomarkers in the brain that track closely with Alzheimer’s disease progression. If further studies confirm their latest findings, Nasca says the team’s research ...

Roche and Eli Lilly have started testing a blood test that could be used to diagnose Alzheimer’s before symptoms arise, providing an alternative to expensive brain scans and speeding up the ...

Dr. Nasca says that if further studies confirm their latest findings, the team's research could be used to develop a blood test for dementia and for tracking the progression of Alzheimer's disease ...

The team's goal is to define other biomarkers in the brain that track closely with Alzheimer's disease progression. If further studies confirm their latest findings, Nasca says the team's research ...

Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for ...